long intergenic non-protein coding RNA 1928Genealiases: []
Q-omics provides the consensus-scored LINC01928 profile across patient tissues and cancer cell-line models. LINC01928 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC01928 is differentially expressed in 4, with the highest sampling consensus in KIRP. Additionally, LINC01928 RNA expression shows 6,282 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight UVM, and KIRP as cancer lineages where LINC01928 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01928 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01928 survival associations across molecular data types. LINC01928 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01928 RNA expression–survival associations across cancer types. High LINC01928 expression shows unfavorable associations in UVM, DLBC, BLCA, LIHC, SKCM and KICH. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC01928 RNA expression.
This table summarizes LINC01928 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01928. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01928 shows lower tumor expression in KIRP, KIRC, KICH and LIHC. The KIRP box plot shows higher LINC01928 RNA expression in normal versus tumor tissue (log2 FC = −1.643, t-test p < 0.001).
This table shows molecular features associated with LINC01928 in patient tissues and cancer cell lines. In patient samples, LINC01928 shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
